{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T01:49:26Z","timestamp":1795052966599,"version":"4.10.2"},"reference-count":37,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,12]]},"abstract":"<jats:sec>\n            <jats:title>OBJECTIVE:<\/jats:title>\n            <jats:p>To estimate the association between use of an intrauterine device (IUD) and risk of cervical cancer by subjecting existing data to critical review, quantitative synthesis, and interpretation.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>DATA SOURCES:<\/jats:title>\n            <jats:p>We searched PubMed, Web of Science, ClinicalTrials.gov, and catalogs of scientific meetings and abstracts, theses, and dissertations queried from inception through July 2016.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>METHODS OF STUDY SELECTION:<\/jats:title>\n            <jats:p>Examination of abstracts from 225 reports identified 34 studies with individual-level measures of use of an IUD and incident cervical cancer. By critically assessing the full text of these reports, independent reviewers identified 17 studies conducted without recognized sources of systematic error, of which 16 could be harmonized for meta-analysis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>TABULATION, INTEGRATION, AND RESULTS:<\/jats:title>\n            <jats:p>Point and interval estimates of the association between use of an IUD and incident cervical cancer were extracted from original reports into a structured database along with key features of study design and implementation. A random-effects meta-analysis was implemented to quantitatively synthesize extracted estimates and assess likely influence of publication bias, residual confounding, heterogeneity of true effect size, and human papillomavirus prevalence and cervical cancer incidence in source populations. Women who used an IUD experienced less cervical cancer (summary odds ratio 0.64, 95% CI 0.53\u20130.77). Neither confounding by recognized risk factors nor publication bias seems a plausible explanation for the apparent protective effect, which may be stronger in populations with higher cervical cancer incidence.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>CONCLUSION:<\/jats:title>\n            <jats:p>Invasive cervical cancer may be approximately one third less frequent in women who have used an IUD. This possible noncontraceptive benefit could be most beneficial in populations with severely limited access to screening and concomitantly high cervical cancer incidence.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/aog.0000000000002307","type":"journal-article","created":{"date-parts":[[2017,11,22]],"date-time":"2017-11-22T19:13:36Z","timestamp":1511378016000},"page":"1226-1236","source":"Crossref","is-referenced-by-count":78,"title":["Intrauterine Device Use and Cervical Cancer Risk"],"prefix":"10.1097","volume":"130","author":[{"given":"Victoria K.","family":"Cortessis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malcolm","family":"Barrett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niquelle","family":"Brown Wade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Temuulen","family":"Enebish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith L.","family":"Perrigo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Tobin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlie","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Zink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa","family":"Isiaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laila I.","family":"Muderspach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Natavio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"McKean-Cowdin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230711","doi-asserted-by":"crossref","first-page":"E359","DOI":"10.1002\/ijc.29210","article-title":"Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012","volume":"136","author":"Ferlay","year":"2015","journal-title":"Int J Cancer"},{"key":"R2-20230711","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0140-6736(04)16674-9","article-title":"The cervical cancer epidemic that screening has prevented in the UK","volume":"364","author":"Peto","year":"2004","journal-title":"Lancet"},{"key":"R3-20230711","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1002\/cncr.30507","article-title":"Hysterectomy-corrected cervical cancer mortality rates reveal a larger racial disparity in the United States","volume":"123","author":"Beavis","year":"2017","journal-title":"Cancer"},{"key":"R4-20230711","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1158\/1940-6207.CAPR-11-0447","article-title":"A review of cancer in U.S. Hispanic populations","volume":"5","author":"Haile","year":"2012","journal-title":"Cancer Prev Res"},{"key":"R5-20230711","doi-asserted-by":"crossref","first-page":"e453","DOI":"10.1016\/S2214-109X(16)30099-7","article-title":"Global estimates of human papillomavirus vaccination coverage by region and income level: a pooled analysis","volume":"4","author":"Bruni","year":"2016","journal-title":"Lancet Glob Health"},{"key":"R7-20230711","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1093\/humupd\/dmv023","article-title":"Non-contraceptive benefits of hormonal and intrauterine reversible contraceptive methods","volume":"21","author":"Bahamondes","year":"2015","journal-title":"Hum Reprod Update"},{"key":"R8-20230711","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.annepidem.2007.11.011","article-title":"Meta-analysis of intrauterine device use and risk of endometrial cancer","volume":"18","author":"Beining","year":"2008","journal-title":"Ann Epidemiol"},{"key":"R9-20230711","doi-asserted-by":"crossref","first-page":"E410","DOI":"10.1002\/ijc.29229","article-title":"Intrauterine devices and endometrial cancer risk: a pooled analysis of the epidemiology of endometrial cancer consortium","volume":"136","author":"Felix","year":"2015","journal-title":"Int J Cancer"},{"key":"R10-20230711","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/S1470-2045(11)70223-6","article-title":"Intrauterine device use, cervical infection with human papillomavirus, and risk of cervical cancer: a pooled analysis of 26 epidemiological studies","volume":"12","author":"Castellsagu\u00e9","year":"2011","journal-title":"Lancet Oncol"},{"key":"R11-20230711","doi-asserted-by":"crossref","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med"},{"key":"R12-20230711","first-page":"1063","article-title":"Risk factors for invasive cervical cancer among Latinas and non-Latinas in Los Angeles County","volume":"77","author":"Peters","year":"1986","journal-title":"J Natl Cancer Inst"},{"key":"R14-20230711","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Stat Med"},{"key":"R15-20230711","doi-asserted-by":"crossref","first-page":"e0147029","DOI":"10.1371\/journal.pone.0147029","article-title":"The influence of hormonal factors on the risk of developing cervical cancer and pre-cancer: results from the EPIC cohort","volume":"11","author":"Roura","year":"2016","journal-title":"PLoS One"},{"key":"R16-20230711","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1002\/ijc.20600","article-title":"Cervical carcinoma in Algiers, Algeria: human papillomavirus and lifestyle risk factors","volume":"113","author":"Hammouda","year":"2005","journal-title":"Int J Cancer"},{"key":"R17-20230711","doi-asserted-by":"crossref","first-page":"e19244","DOI":"10.1371\/journal.pone.0019244","article-title":"Prevalence and risk factors of human papillomavirus (HPV) infection in southern Chinese women\u2014a population-based study","volume":"6","author":"Liu","year":"2011","journal-title":"PLoS One"},{"key":"R19-20230711","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1002\/(SICI)1097-0215(19980209)75:4<546::AID-IJC9>3.0.CO;2-T","article-title":"The viral origin of cervical cancer in Rabat, Morocco","volume":"75","author":"Chaouki","year":"1998","journal-title":"Int J Cancer"},{"key":"R20-20230711","first-page":"415","article-title":"Human papillomavirus and cervical intraepithelial neoplasia grade III\/carcinoma in situ: a case-control study in Spain and Colombia","volume":"2","author":"Bosch","year":"1993","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"R21-20230711","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1002\/ijc.11350","article-title":"Human papillomavirus and risk factors for cervical cancer in Chennai, India: a case-control study","volume":"107","author":"Franceschi","year":"2003","journal-title":"Int J Cancer"},{"key":"R22-20230711","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1093\/jnci\/90.1.50","article-title":"Risk factors for cervical cancer in Thailand: a case-control study","volume":"90","author":"Chichareon","year":"1998","journal-title":"J Natl Cancer Inst"},{"key":"R23-20230711","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1093\/jnci\/90.1.43","article-title":"Causes of cervical cancer in the Philippines: a case-control study","volume":"90","author":"Ngelangel","year":"1998","journal-title":"J Natl Cancer Inst"},{"key":"R24-20230711","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1054\/bjoc.2001.1948","article-title":"HPV types and cofactors causing cervical cancer in Peru","volume":"85","author":"Santos","year":"2001","journal-title":"Br J Cancer"},{"key":"R26-20230711","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1093\/annonc\/mdm079","article-title":"Burden of cervical cancer in Europe: estimates for 2004","volume":"18","author":"Arbyn","year":"2007","journal-title":"Ann Oncol"},{"key":"R27-20230711","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0020-7292(01)00560-4","article-title":"HIV and cervical cancer in Kenya","volume":"76","author":"Gichangi","year":"2002","journal-title":"Int J Gynaecol Obstet"},{"key":"R28-20230711","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/s11670-011-0010-x","article-title":"Incidence and mortality trend of cervical cancer in 11 cancer registries of China","volume":"23","author":"Lei","year":"2011","journal-title":"Chin J Cancer Res"},{"key":"R32-20230711","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1093\/ije\/19.1.4","article-title":"Oral contraceptive use and risk of invasive cervical cancer","volume":"19","author":"Brinton","year":"1990","journal-title":"Int J Epidemiol"},{"key":"R33-20230711","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1093\/ije\/23.5.906","article-title":"Risk factors for invasive cervical cancer in Kenyan women","volume":"23","author":"Williams","year":"1994","journal-title":"Int J Epidemiol"},{"key":"R34-20230711","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1158\/1055-9965.1574.13.10","article-title":"A case-control study of risk factors for invasive cervical cancer among U.S. women exposed to oncogenic types of human papillomavirus","volume":"13","author":"Shields","year":"2004","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"R35-20230711","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1093\/oxfordjournals.aje.a114699","article-title":"The role of contraceptive use in cervical cancer: the Maryland Cervical Cancer Case-Control Study","volume":"126","author":"Celentano","year":"1987","journal-title":"Am J Epidemiol"},{"key":"R36-20230711","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1093\/ije\/20.4.865","article-title":"Invasive cervical cancer and intrauterine device use","volume":"20","author":"Lassise","year":"1991","journal-title":"Int J Epidemiol"},{"key":"R37-20230711","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1093\/ije\/21.5.1030","article-title":"Use of intrauterine device and risk of invasive cervical cancer","volume":"21","author":"Parazzini","year":"1992","journal-title":"Int J Epidemiol"},{"key":"R38-20230711","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1089\/152460900318498","article-title":"Tubal sterilization and use of an IUD and risk of cervical cancer","volume":"9","author":"Li","year":"2000","journal-title":"J Womens Health Gend Based Med"},{"key":"R39-20230711","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1093\/ije\/31.2.422","article-title":"Estimating causal effects","volume":"31","author":"Maldonado","year":"2002","journal-title":"Int J Epidemiol"},{"key":"R40-20230711","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1095\/biolreprod.105.043133","article-title":"Immunological microenvironments in the human vagina and cervix: mediators of cellular immunity are concentrated in the cervical transformation zone","volume":"73","author":"Pudney","year":"2005","journal-title":"Biol Reprod"},{"key":"R41-20230711","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/S1470-2045(11)70255-8","article-title":"Loops in the natural history of cervical cancer","volume":"12","author":"Petry","year":"2011","journal-title":"Lancet Oncol"},{"key":"R42-20230711","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1002\/ijc.2910570612","article-title":"Cellular immunodeficiency enhances the progression of human papillomavirus-associated cervical lesions","volume":"57","author":"Petry","year":"1994","journal-title":"Int J Cancer"},{"key":"R43-20230711","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.critrevonc.2012.02.008","article-title":"HPV-related (pre)malignancies of the female anogenital tract in renal transplant recipients","volume":"84","author":"Hinten","year":"2012","journal-title":"Crit Rev Oncol Hematol"},{"key":"R44-20230711","doi-asserted-by":"crossref","first-page":"831907","DOI":"10.1155\/2013\/831907","article-title":"Prognostic significance of immunohistochemical phenotypes in patients treated for high-grade cervical intraepithelial neoplasia","volume":"2013","author":"Origoni","year":"2013","journal-title":"Biomed Res Int"}],"container-title":["Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00006250-201712000-00007","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,11]],"date-time":"2023-07-11T18:08:28Z","timestamp":1689098908000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006250-201712000-00007"}},"subtitle":["A Systematic Review and Meta-analysis"],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":37,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/aog.0000000000002307","relation":{},"ISSN":["0029-7844"],"issn-type":[{"value":"0029-7844","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]}}}